168 related articles for article (PubMed ID: 21625164)
1. Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Timmerman R; Bastasch M; Saha D; Abdulrahman R; Hittson W; Story M
Front Radiat Ther Oncol; 2011; 43():382-394. PubMed ID: 21625164
[TBL] [Abstract][Full Text] [Related]
2. Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.
Timmerman R; Bastasch M; Saha D; Abdulrahman R; Hittson W; Story M
Front Radiat Ther Oncol; 2007; 40():352-365. PubMed ID: 17641519
[TBL] [Abstract][Full Text] [Related]
3. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.
Sahgal A; Roberge D; Schellenberg D; Purdie TG; Swaminath A; Pantarotto J; Filion E; Gabos Z; Butler J; Letourneau D; Masucci GL; Mulroy L; Bezjak A; Dawson LA; Parliament M;
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):629-39. PubMed ID: 22633542
[TBL] [Abstract][Full Text] [Related]
4. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.
Ding C; Solberg TD; Hrycushko B; Xing L; Heinzerling J; Timmerman RD
Med Phys; 2013 May; 40(5):051705. PubMed ID: 23635253
[TBL] [Abstract][Full Text] [Related]
5. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
6. The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy.
Kavanagh BD; Timmerman R; Meyer JL
Front Radiat Ther Oncol; 2011; 43():370-381. PubMed ID: 21625163
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery/stereotactic body radiation therapy-reflection on the last decade's achievements and future directions.
Knisely J; Sahgal A; Lo S; Ma L; Chang E
Ann Palliat Med; 2016 Apr; 5(2):139-44. PubMed ID: 27121742
[TBL] [Abstract][Full Text] [Related]
9. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer: a model for implementing stereotactic body radiation therapy into practice.
Timmerman R; Abdulrahman R; Kavanagh BD; Meyer JL
Front Radiat Ther Oncol; 2007; 40():368-385. PubMed ID: 17641520
[TBL] [Abstract][Full Text] [Related]
11. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for prostate cancer: Rational and reasonable.
Kupelian P; Mehta NH; King C; Steinberg M; Finkelstein SE; Fernandez E
Pract Radiat Oncol; 2015; 5(3):188-192. PubMed ID: 25413392
[TBL] [Abstract][Full Text] [Related]
13. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
14. Emerging technologies in stereotactic body radiotherapy.
Ma L; Wang L; Tseng CL; Sahgal A
Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S12. PubMed ID: 28917250
[TBL] [Abstract][Full Text] [Related]
15. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?
Brown JM; Carlson DJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):254-62. PubMed ID: 24411596
[TBL] [Abstract][Full Text] [Related]
16. Extracranial stereotactic radioablation: physical principles.
Papiez L; Timmerman R; DesRosiers C; Randall M
Acta Oncol; 2003; 42(8):882-94. PubMed ID: 14968949
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
Doi H; Beppu N; Kitajima K; Kuribayashi K
Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
Folkert MR; Timmerman RD
Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
[TBL] [Abstract][Full Text] [Related]
19. Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study.
Versteeg AL; Hes J; van der Velden JM; Eppinga W; Kasperts N; Verkooijen HM; van Vulpen M; Oner FC; Seravalli E; Verlaan JJ
Acta Oncol; 2019 Feb; 58(2):251-256. PubMed ID: 30513233
[TBL] [Abstract][Full Text] [Related]
20. Safety Considerations in Stereotactic Body Radiation Therapy.
Ford E; Dieterich S
Semin Radiat Oncol; 2017 Jul; 27(3):190-196. PubMed ID: 28577826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
